LTC4

Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.

Cross Reference

Introduction

To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTC4?

LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTC4

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Acute-Phase Reaction D000210 12 associated lipids
Airway Obstruction D000402 13 associated lipids
Anaphylaxis D000707 35 associated lipids
Angina Pectoris D000787 27 associated lipids
Arthritis D001168 41 associated lipids
Asbestosis D001195 8 associated lipids
Asthma D001249 52 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Cholestasis, Extrahepatic D001651 7 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cestode Infections D002590 3 associated lipids
Colitis D003092 69 associated lipids
Common Bile Duct Diseases D003137 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Ear Diseases D004427 7 associated lipids
Edema D004487 152 associated lipids
Eosinophilia D004802 4 associated lipids
Gastritis D005756 27 associated lipids
Glioma D005910 112 associated lipids
Glomerulonephritis D005921 35 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypotension D007022 41 associated lipids
Inflammation D007249 119 associated lipids
Insect Bites and Stings D007299 4 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mesenteric Vascular Occlusion D008641 4 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Nasal Polyps D009298 26 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Peritonitis D010538 38 associated lipids
Phlebitis D010689 1 associated lipids
Picornaviridae Infections D010850 4 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Per page 10 20 50 100 | Total 75

PubChem Associated disorders and diseases

What pathways are associated with LTC4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTC4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTC4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTC4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTC4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTC4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTC4

Download all related citations
Per page 10 20 50 100 | Total 1173
Authors Title Published Journal PubMed Link
Olynych TJ et al. Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. 2006 J. Allergy Clin. Immunol. pmid:17030235
Lee KS et al. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice. 2007 J. Allergy Clin. Immunol. pmid:17208595
Hamilton RG and Franklin Adkinson N In vitro assays for the diagnosis of IgE-mediated disorders. 2004 J. Allergy Clin. Immunol. pmid:15316492
Macglashan DW and Saini SS Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation. 2013 J. Allergy Clin. Immunol. pmid:23791510
Kowalski ML et al. Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. 2003 J. Allergy Clin. Immunol. pmid:13679808
Triggiani M et al. Lung mast cells are a source of secreted phospholipases A2. 2009 J. Allergy Clin. Immunol. pmid:19541351
Di Capite J et al. Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis. 2009 J. Allergy Clin. Immunol. pmid:19895990
Miura K et al. Phosphorylation of cytosolic phospholipase A2 by IL-3 is associated with increased free arachidonic acid generation and leukotriene C4 release in human basophils. 1998 J. Allergy Clin. Immunol. pmid:9768595
Meliton AY et al. Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils. 2003 J. Allergy Clin. Immunol. pmid:12897749
Oskeritzian CA et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. 2005 J. Allergy Clin. Immunol. pmid:15940129
Shilling AD et al. Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane. 2006 May-Jun J Pharmacol Toxicol Methods pmid:16176877
Ramis I et al. Application of totally automated on-line sample clean up system for extraction and high-performance liquid chromatography separation of peptide leukotrienes. 1993 Nov-Dec J Pharm Biomed Anal pmid:8123725
Syslová K et al. Immunomagnetic molecular probe with UHPLC-MS/MS: a promising way for reliable bronchial asthma diagnostics based on quantification of cysteinyl leukotrienes. 2013 Jul-Aug J Pharm Biomed Anal pmid:23644905
Herron DK et al. Visualization and comparison of molecular dynamics simulations of leukotriene C4, leukotriene D4, and leukotriene E4. 1995 J Mol Graph pmid:8820302
Jakobsson PJ et al. Characterization of microsomal GST-II by western blot and identification of a novel LTC4 isomer. 1997 J Lipid Mediat Cell Signal pmid:9302651
Lam BK et al. Leukotriene C4 synthase. 1995 J Lipid Mediat Cell Signal pmid:8777577
Liebhart J et al. Production of leukotriene C4 by peripheral blood leukocytes stimulated with anti-fcepsilonRI antibody, PMA, and fMLP does not correlate with irreversible airway obstruction in asthmatics. 2007 J Investig Allergol Clin Immunol pmid:17323856
Annila I et al. Bee venom induces high histamine or high leukotriene C4 release in skin of sensitized beekeepers. 2000 Jul-Aug J Investig Allergol Clin Immunol pmid:11039839
Kimura Y et al. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. 1995 J Ethnopharmacol pmid:7776662
Abad MJ et al. Anti-inflammatory activity of four Bolivian Baccharis species (Compositae). 2006 J Ethnopharmacol pmid:16202549
Quan Z et al. Ethanol extracts of Saururus chinensis suppress ovalbumin-sensitization airway inflammation. 2010 J Ethnopharmacol pmid:20699114
Di Sotto A et al. Pharmacological and phytochemical study on a Sisymbrium officinale Scop. extract. 2010 J Ethnopharmacol pmid:19969059
Yang SH and Yu CL Antiinflammatory effects of Bu-zhong-yi-qi-tang in patients with perennial allergic rhinitis. 2008 J Ethnopharmacol pmid:17980528
Hamasaki Y et al. The Chinese herbal medicine, shinpi-to, inhibits IgE-mediated leukotriene synthesis in rat basophilic leukemia-2H3 cells. 1997 J Ethnopharmacol pmid:9174973
Kjellström S et al. On-line coupling of microdialysis sampling with liquid chromatography for the determination of peptide and non-peptide leukotrienes. 1998 J Chromatogr A pmid:9818423
Al-Amran FG et al. Leukotriene biosynthesis inhibition ameliorates acute lung injury following hemorrhagic shock in rats. 2011 J Cardiothorac Surg pmid:21649921
Heredi-Szabo K et al. Characterization of 5(6)-carboxy-2,'7'-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4. 2008 J Biomol Screen pmid:18349419
Mitsunobu F et al. Different roles of histamine and leukotriene C4 in the airways between patients with atopic and nonatopic asthma. 1998 J Asthma pmid:9669831
Xu R et al. Novel polyhydroxylated steroids from the East China Sea gorgonian Echinogorgia sassapo reticulata with suppressive activity of leukotriene C4 generation and degranulation in bone marrow-derived mast cells. 2014 J Asian Nat Prod Res pmid:24437431
Sciuto AM et al. Post-exposure treatment with isoproterenol attenuates pulmonary edema in phosgene-exposed rabbits. 1998 Sep-Oct J Appl Toxicol pmid:9804432
Okamoto M et al. Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. 2000 Intern. Med. pmid:10732825
Daugschies A and Ruttkowski B Modulation of migration of Oesophagostomum dentatum larvae by inhibitors and products of eicosanoid metabolism. 1998 Int. J. Parasitol. pmid:9513001
Meier HL et al. Simultaneous initiation of degranulation and inhibition of leukotriene release by soman in human basophils. 1995 Int. J. Immunopharmacol. pmid:7545649
Hamasaki Y et al. (9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesis. 2000 Int. J. Immunopharmacol. pmid:10785545
Vigorito C et al. Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man. 1997 Int. J. Clin. Lab. Res. pmid:9352380
Sharma R et al. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance. 2004 Int. J. Cancer pmid:15386349
Meszaros P et al. Long term myriocin treatment increases MRP1 transport activity. 2013 Int. J. Biochem. Cell Biol. pmid:23178537
Jung HW et al. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis. 2013 Int. Immunopharmacol. pmid:23643816
Muraki M et al. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication. 2009 Int. Immunopharmacol. pmid:19706339
Fujisaki T et al. Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia. 2003 Int. Immunopharmacol. pmid:12781706
Yang SH et al. The stimulatory effects of nasal discharge from patients with perennial allergic rhinitis on normal human neutrophils are normalized after treatment with a new mixed formula of Chinese herbs. 2002 Int. Immunopharmacol. pmid:12469937
Rossi MI et al. Long-term exacerbation by interleukin 13 of IgE-mediated eosinophilia in rats. 2005 Int. Immunopharmacol. pmid:15953562
Nunomura S et al. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE. 2005 Int. Immunol. pmid:15944196
Georgitis JW et al. Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid. 1995 Int. Arch. Allergy Immunol. pmid:7719157
Genovese A et al. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. 2003 Int. Arch. Allergy Immunol. pmid:14707465
Genovese A et al. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. 1996 Int. Arch. Allergy Immunol. pmid:8645973
Davoine F et al. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis. 2006 Int. Arch. Allergy Immunol. pmid:16735797
Patella V et al. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. 1996 Int. Arch. Allergy Immunol. pmid:8753840
Hirano T et al. Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. 2004 Int. Arch. Allergy Immunol. pmid:15153793
Iwamoto I et al. Effect of a selective thromboxane A2 receptor antagonist BAY u3405 on antigen-, leukotriene C4- and leukotriene D4-induced bronchoconstriction in guinea pigs. 1995 Int. Arch. Allergy Immunol. pmid:7647588
Ilarraza R et al. Montelukast inhibits leukotriene stimulation of human dendritic cells in vitro. 2012 Int. Arch. Allergy Immunol. pmid:22846852
Hashimoto K et al. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. 2009 Int. Arch. Allergy Immunol. pmid:19218821
Koketsu R et al. Pretreatment with low levels of FcεRI-crosslinking stimulation enhances basophil mediator release. 2013 Int. Arch. Allergy Immunol. pmid:23711850
James A et al. The influence of aspirin on release of eoxin C4, leukotriene C4 and 15-HETE, in eosinophilic granulocytes isolated from patients with asthma. 2013 Int. Arch. Allergy Immunol. pmid:23921438
Itoh K et al. Relationship between airway eosinophilia and airway hyperresponsiveness in a late asthmatic model of guinea pigs. 1996 Int. Arch. Allergy Immunol. pmid:8527956
Kawashima T et al. Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils. 1994 Int. Arch. Allergy Immunol. pmid:8130655
Wang D et al. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. 1995 Int. Arch. Allergy Immunol. pmid:7888790
Kitahata Y et al. Prolonged culture of mast cells with high-glucose medium enhances the Fc epsilon RI-mediated degranulation response and leukotriene C4 production. 2010 Int. Arch. Allergy Immunol. pmid:20523060
Patella V et al. Human heart mast cells: a definitive case of mast cell heterogeneity. 1995 Int. Arch. Allergy Immunol. pmid:7536502
Lebel B et al. Inhibition of mediator release from dispersed nasal polyp cells by cyclosporin A. 1998 Int. Arch. Allergy Immunol. pmid:9693278
Austen KF The Paul Kallós Memorial Lecture. From slow-reacting substance of anaphylaxis to leukotriene C4 synthase. 1995 May-Jun Int. Arch. Allergy Immunol. pmid:7613129
Tsai JJ et al. Relationship between nasal resistance and airway hyperreactivity following nasal provocation with Dermatophagoides pteronyssinus in allergic rhinitis. 1995 Int. Arch. Allergy Immunol. pmid:7888791
Weber M and Dahinden CA Basophil and eosinophil activation by CC chemokines. 1995 May-Jun Int. Arch. Allergy Immunol. pmid:7542061
Kang BC et al. Experimental asthma developed by room air contamination with cockroach allergen. 1996 Int. Arch. Allergy Immunol. pmid:8917126
Takafuji S et al. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils. 1995 Int. Arch. Allergy Immunol. pmid:7549519
Yoshida K et al. Effect of fibronectin on the production of leukotriene C4 by eosinophils. 1995 Int. Arch. Allergy Immunol. pmid:7549524
Bossé M et al. Eosinophil activation status and corticosteroid responsiveness in severe asthma. 2000 Int. Arch. Allergy Immunol. pmid:10899764
Marone G et al. Human heart mast cells in anaphylaxis and cardiovascular disease. 1995 May-Jun Int. Arch. Allergy Immunol. pmid:7542106
Okamoto M et al. Effects of perilla seed oil supplementation on leukotriene generation by leucocytes in patients with asthma associated with lipometabolism. 2000 Int. Arch. Allergy Immunol. pmid:10878492
Kloprogge E et al. Cellular communication in leukotriene C4 production between eosinophils and neutrophils. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2509375
Schauer U et al. Enhanced leukotriene C4 production by peripheral eosinophilic granulocytes from children with asthma. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2512259
Oh YC et al. Anti-allergic activity of a platycodon root ethanol extract. 2010 Int J Mol Sci pmid:20717534
Borrelli I et al. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils. 2010 Jul-Sep Int J Immunopathol Pharmacol pmid:20943043
Cotti E and Torabinejad M Detection of leukotriene C4 in human periradicular lesions. 1994 Int Endod J pmid:8034369
Tarnay JN et al. The dMRP/CG6214 gene of Drosophila is evolutionarily and functionally related to the human multidrug resistance-associated protein family. 2004 Insect Mol. Biol. pmid:15373810
Hung ND et al. Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis. 2011 Inflammation pmid:20490641
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
Han YS et al. Macelignan inhibits histamine release and inflammatory mediator production in activated rat basophilic leukemia mast cells. 2012 Inflammation pmid:22729280
Schuligoi R et al. Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells. 1998 Inflamm. Res. pmid:9657255
Akasaka R et al. Effects of three different Ca(2+)-ATPase inhibitors on Ca2+ response and leukotriene release in RBL-2H3 cells. 1996 Inflamm. Res. pmid:8988402
Omar HM et al. Hepatobiliary excretion of cysteinyl leukotrienes in three experimental models of acute hepatic injury. 1996 Inflamm. Res. pmid:8912018
Ebihara S et al. A simple preparation method for mouse eosinophils and their responses to anti-allergic drugs. 2007 Inflamm. Res. pmid:17406808
Horizoe T et al. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model. 1998 Inflamm. Res. pmid:9831321
Ohashi H et al. Sulochrin inhibits eosinophil activation and chemotaxis. 1998 Inflamm. Res. pmid:9831326
Theron AJ et al. Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants. 2009 Inflamm. Res. pmid:19184354
Daffonchio L et al. Protective activity of ketoprofen lysine salt against the pulmonary effects induced by bradykinin in guinea-pigs. 1996 Inflamm. Res. pmid:8737750
Inoue H et al. Inhibition by actinomycin D of neurogenic mouse ear oedema. 1995 Inflamm. Res. pmid:7552577
Franco L and Velo GP Eicosanoid and gastroprotection by copper derivatives and NDGA. 1995 Inflamm. Res. pmid:7552579
Ko JK and Cho CH Co-regulation of mucosal nitric oxide and prostaglandin in gastric adaptive cytoprotection. 1999 Inflamm. Res. pmid:10522801
Gibbs BF et al. Ambroxol inhibits IgE-dependent mediator secretion from human skin mast cells. 2000 Inflamm. Res. pmid:10864402
Urasaki T et al. Cytosolic phospholipase A2, increased and activated in the eosinophils of patients with hypereosinophilic syndrome in vivo, is involved in the augmented release of leukotriene C4. 1999 Inflamm. Res. pmid:9987681
Urasaki T et al. Induction of the activation-related antigen CD69 on human eosinophils by type IIA phospholipase A2. 2000 Inflamm. Res. pmid:10858018
Dent G et al. Up-regulation of human eosinophil leukotriene C4 generation through contact with bronchial epithelial cells. 2000 Inflamm. Res. pmid:10893047
Amann R et al. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung. 2001 Inflamm. Res. pmid:11235022
Amann R et al. Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification. 1999 Inflamm. Res. pmid:10669114
Sperber K et al. Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues. 1998 Inflamm. Bowel Dis. pmid:9552223
Genovese A et al. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. 2000 Infect. Immun. pmid:10992448
Pelclová D et al. Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis. 2012 Ind Health pmid:22785421
Mochizuki Y et al. Suppressive activity of epinastine hydrochloride on eosinophil activation in vitro. 2008 Jan-Feb In Vivo pmid:18396776
Chae HS and Chin YW Anti-allergic effect of lambertianic acid from Thuja orientalis in mouse bone marrow-derived mast cells. 2012 Immunopharmacol Immunotoxicol pmid:21854102